Aim-To investigate the use of the polymerase chain reaction (PCR) in the routine laboratory for the detection of Mycobacterium tuberculosis in clinical samples. Methods-Samples were divided and processed separately for the detection of M tuberculosis by microscopy, culture and PCR. After DNA extraction, PCR was performed with primers specific for the insertion element IS6110 and the product was analysed by agarose gel electrophoresis, Southern blotting or dot blotting and hybridisation with a digoxigenin labelled internal probe. Each sample was tested for inhibitors of Taq polymerase with the aid ofan internal control. Multiple negative and positive controls were used to monitor each step of the procedure. Results-The data from two laboratories, using the same operating procedures, were combined. Of 1957 specimens, 79 (4%) were culture and PCR positive, while 1839 (93.9%) were negative in both tests. Thirty specimens (1-5%) were PCR positive only and nine (0.5%) were culture positive but PCR negative. Conclusion-Using culture and clinical history as the gold standard, sensitivity and specificity for PCR were 92-1% and 99-8%, respectively. With elaborate precautions, PCR is a suitable and reliable method for the detection ofM tuberculosis in clinical samples in a routine microbiology laboratory. (J Clin Pathol 1995;48:810-814) 
After years of declining incidence, the number of registered patients with tuberculosis in The Netherlands has increased since 1987.1 Rapid diagnosis of infectious cases of tuberculosis is of major importance for public health services.2 Drawbacks of the conventional Mycobacterium tuberculosis detection techniques are that direct staining for acid fast bacilli lacks sensitivity and specificity and that culturing of mycobacteria is very time-consuming. Furthermore, microscopy and culture are difficult in cases of extrapulmonary infection, and it is for this reason that some laboratories still use inoculation of guinea pigs for samples which are difficult to obtain. With the polymerase chain reaction (PCR) it is possible to identify M tuberculosis directly in clinical samples.3 Many papers describe the development and the use of DNA amplification methods for detection ofM tuberculosis. 4 However, Noordhoek et al recently showed that reliable detection of M tuberculosis using PCR can be difficult because of the occurrence of false positive results through contamination and lack of sensitivity, usually caused by inhibition of Taq polymerase by biological substances present in the sample. 45 In The Netherlands, the prevalence of tuberculosis infections is still very low, less than 4% ofthe samples submitted to a routine laboratory are culture positive for M tuberculosis. Thus, if the few positive results are not to be missed, the sensitivity of a rapid and specific test needs to be close to 100%. To investigate the feasibility of routine PCR testing in a clinical laboratory, both conventional tests and PCR were carried out on a large number of clinical samples. Insertion sequence IS6110, which is specific for the M tuberculosis complex group of bacteria, was used as the target for DNA amplification.346`8 The protocol was optimised to obtain maximal sensitivity and specificity.
Methods

CLINICAL SPECIMENS
The samples tested at the microbiology departments of the Leeuwarden or Enschede Public Health Laboratories were routine specimens obtained from patients suspected of having tuberculosis. In Leeuwarden some of the samples were preselected. During the first four months ofthe project, all sputum and bronchial washings received in the laboratory were included in the study. Thereafter, PCR on sputum and bronchial washings was carried out only when acid fast bacilli were found on microscopy or when there was strong clinical evidence of tuberculosis. On the day of receipt, taking appropriate precautions in a laminar flow hood, the specimens were divided into two portions, one for PCR and one for conventional detection methods. In the mycobacteria laboratory, direct smears were analysed for acid fast bacilli using microscopy after staining with auramine and/or Ziehl-Neelsen. Sputum, bronchial washing and pleural fluid samples were decontaminated using standard procedures9 and inoculated onto Lowenstein-Jensen medium. Specimens from other sites of the body were, after standard pretreatment, inoculated onto Lowenstein-Jensen and/or Middlebrook 7H1 1 medium.
PRETREATMENT OF SAMPLES FOR PCR PCR was performed according to the recommendations of Kwok,'0 using three separate locations for the preparation of the PCR reaction mixture, sample and DNA preparation, and the analysis of PCR products, respectively. Positive displacement pipettes or filtertips were used throughout and for most of the specimens dUTP-uracil-N-glycosylase (UDG) (Gibco-BRL) was used to avoid contamination with amplicons from previous reactions.8"' Sputum, bronchial washing, pleural fluid, and pus samples were pretreated with 1 to 10 volumes of 0 5 M NaOH/0 05 M sodium citrate/0-5% N-acetyl-L-cysteine and centrifuged for 15 minutes at 15 000 x g in a microcentrifuge. Samples which did not need liquefaction, such as urine and cerebrospinal fluid, were concentrated by centrifugation at 15000 x g in a microcentrifuge. The pellets were washed once with a solution containing 1% Triton X100, 20mM Tris/HCl (pH 8-3) and 1 mM EDTA (TEX), and resuspended in 100pd TEX. Tissue biopsy specimens were homogenised with razor blades and incubated for 12 to 16 hours at 55°C in 100 to 500,l lysis buffer containing 1 % sodium dodecyl sulphate (SDS), 1001g/ml proteinase K in 10 mM Tris/ HC1 (pH Performance of the amplification reaction was monitored by testing one sample without DNA and three samples containing 2-5, 25 and 250 fg M tuberculosis DNA. The PCR was performed in a thermocycler (Perkin Elmer 480 or Bio-med 60 for Leeuwarden and Enschede, respectively). In Leeuwarden the PCR cycle profile was optimised by using a "touch down" protocol to increase the specificity of the reaction.14 The reaction started with six minutes at 37°C for UDG incubation and six minutes at 94°C for UDG inactivation and DNA denaturation, followed by PCR cycles of one minute at 94°C for denaturation, one minute for primer annealing and one minute for primer extension at 72°C. The We found nine PCR negative samples, alt DNA though acid fast bacilli were observed in direct Leeu-smears and M tuberculosis was cultured. The M in nine tuberculosis strains cultured from these samples rsistent were all PCR positive, indicating that the -s were IS6110 fragment was present. The negative ion, 61 PCR results in these clinical specimens were tion.
probably because of unequal distribution of mycobacteria in the sample. In the smear preparations few acid fast bacilli were observed AND and only one or two of the three inoculated tubes containing Lowestein-Jensen medium n 1638 were positive. tection
To evaluate our PCR, we have used the nd cul-definitions "true" positive and "true" negative.
We regarded a test result as "true" positive when M tuberculosis was cultured, when direct microscopy and PCR were positive but culture was negative and when direct microscopy and culture were negative but PCR was positive egative and other material from the patient was positive on culture or had been positive in the past. In table 2 the results of culture, microscopy and PCR are compared using the definitions as described above. These results show that our PCR test has a specificity of 99-8% and a sensitivity of 92 1%, whereas culture had a sensitivity of 77-2%. In total, the PCR test was positive in 34 (1.7%) "true" positive samples with a negative microscopy result. Hybridisation of blots increased the sensitivity of the test (data not shown). In a few cases a 245 base pair band was not visible on the gel and was only detected after hybridisation of the Southern blot. Hybridisation was also necessary to control the specificity of the reaction. We found that a Nocardia farcinica isolate from a sputum sample produced a 245 base pair fragment after PCR with the INS 1-INS2 primer set which did not hybridise with the 188 base pair internal probe. This PCR product will be analysed further. 
